Both in Pharmaceuticals
AbCellera Biologics vs Acadia Pharmaceuticals
Over the past year ABCL returned +128.9% and ACAD returned −9.5%; their daily moves had a correlation of 0.21.
ABCL +128.9% ACAD −9.5%Growth of $1, one year, split-adjusted
| Metric | ABCL | ACAD |
|---|---|---|
| Price | $12.27 | $20.59 |
| Market cap | $3.98B | $3.55B |
| Today | −6.19% | −0.82% |
| 1 month | −11.8% | +3.5% |
| 6 months | +177.0% | −6.2% |
| Year to date | +258.8% | −22.9% |
| 1 year | +118.3% | −8.6% |
| Revenue growth (YoY) | −76.3% | +16.4% |
| Gross margin | 100.0% | 90.8% |
| Net margin | −1368.6% | 10.2% |
| P/E (TTM) | — | 9.3× |
| Price / sales | 60.1× | 3.1× |
| Net cash | $540.1M | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 94.9% | 44.3% |
| Short % of float | 14.5% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).